GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Institutional Ownership

PharmaCielo (TSXV:PCLO) Institutional Ownership : 4.73% (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PharmaCielo's institutional ownership is 4.73%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PharmaCielo's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PharmaCielo's Float Percentage Of Total Shares Outstanding is 0.00%.


PharmaCielo Institutional Ownership Historical Data

The historical data trend for PharmaCielo's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Institutional Ownership Chart

PharmaCielo Historical Data

The historical data trend for PharmaCielo can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 5.11 5.02 5.02 4.94 4.94 4.82 4.82 4.74 4.73 4.73

PharmaCielo Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


PharmaCielo (TSXV:PCLO) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.
Executives
Ian D Atacan Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines